Apyx Medical (APYX) Stock Statistics & Valuation Metrics

Apyx Medical has a market cap or net worth of $152.26M. The enterprise value is $159.86M.

Apyx Medical has 41,829,227 shares outstanding. The number of shares has decreased by -2.65% in one year.

Apyx Medical’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -11.60%.

The current PE Ratio of Apyx Medical is ―. Apyx Medical’s PEG ratio is 0.22.

In the last 12 months, Apyx Medical had revenue of 52.84M and earned -11.21M in profits. Earnings per share was -0.27.

In the last 12 months, operating cash flow was -8.00M and capital expenditures -1.11M, giving a free cash flow of -9.11M billion.

Apyx Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Apyx Medical upcoming earnings date is May 7, 2026, After Close (Confirmed).

Apyx Medical as a current ratio of 5.00, with Debt / Equity ratio of 270.56%

In the past 12 months, Apyx Medical has paid 270.00K in taxes.

Apyx Medical EV to EBITDA ratio is -26.80, with an EV/FCF ratio of -17.02.

Apyx Medical has $31.74M in cash and marketable securities with $39.34M in debt, giving a net cash position of -$7.60M billion.

Gross margin is 36.02%, with operating margin of -12.20%, and net profit margin of -21.22%.

The average price target for Apyx Medical is $6.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy